National Institutes of Health
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing March 5, 2027.
Overview
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV…